Intranasal infections with respiratory viruses result in the recruitment of virus-specific CD8+ T cell effectors in the lung during acute infection and persistence of these virus-specific T cells in the respiratory tract months after the infection has resolved [35]–[37]. The gene discussed is CD8A; the disease is infection.